Clinical Study of Ankylosing Spondylitis treated with quqiangtang

Objective:To investigate the clinical efficacy on ankylosing spondylitis(AS)treated with quqiangtang.Methods:102 AS cases were randomly divided into treatment group(52 cases)and control group(50 cases).In control group,aceclofenac enteric-coated tablets and methotrexatum were administered.In treatment group,on the basis of the treatment as control group,quqiangtang and i.v ligustrazine hydrochloride injection were complemented.The observation was conducted in clinical efficacy,clinical and lab indexes between groups.Results:Apparent abnormality was presented in every index before treatment in two groups.After treatment,every index was improved markedly in treatment group(P0.01 or 0.05).The total effective rate(96%)in treatment group was higher than that(70%)in control group,and the adverse response rate(21.6%)was lower apparently than that(34%)in control group.Conclusion:Quqiang tang improves markedly the therapeutic effects on ankylosing spondylitis and reduces adverse response.It is worth to be promoted in clinic.